Stephen Shuttleworth  Chief Operating Officer and Chief Scientific Officer

Stephen joined Karus as CSO in 2008, and in 2017 was appointed COO. He is the founding scientist of Karus’s PI3K-p110β/δ and HDAC6 therapeutic programs. He has a successful track record, gained over 23 years, in the design and dev…

Read more

Penny Ward  Chief Medical Officer

Penny joined Karus in 2013. She is a pharmaceutical physician with Chief Medical Officer and senior management experience gained at Pharmacia and Upjohn (Pfizer), Roche, Novimmune, Glenmark and UCB. Through working extensively in drug developme…

Read more

Simon Jones  Chief Financial Officer

Simon joined Karus in 2012. After graduating in Physics from The University of Warwick, he qualified as a Chartered Accountant in 1992 with the international accountancy firm, Ernst & Young.  Having previously held positions in a number o…

Read more

Elisabeth Bone  Head of Pre-clinical Development

Since graduating from the University of Cambridge and receiving her PhD in Biochemistry and Pharmacology from the University of Sheffield, Elisabeth has worked in a number of research positions.  She has gained important management experien…

Read more